Albert Kildani
Public Communications Contact bei ACADIA PHARMACEUTICALS INC.
Profil
Albert S.
Kildani is currently the SVP-Investor Relations & Corporate Communications at ACADIA Pharmaceuticals, Inc. He is also a member of the National Investor Relations Institute.
Previously, he was the Senior Director-Investor Relations at Hologic, Inc. and Gen-Probe, Inc. He was also a Director at SF Capital Group LLC and a Managing Director at Global Hunter Securities LLC.
Additionally, he served as the VP-Investor Relations & Corporate Communications at Halozyme Therapeutics, Inc. and the VP-Investor Relations & Business Development at Vital Therapies, Inc. Mr. Kildani received his undergraduate degree from Boston College.
Aktive Positionen von Albert Kildani
Unternehmen | Position | Beginn |
---|---|---|
ACADIA PHARMACEUTICALS INC. | Public Communications Contact | 19.09.2023 |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Albert Kildani
Unternehmen | Position | Ende |
---|---|---|
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | Investor Relations Contact | 01.09.2018 |
HOLOGIC, INC. | Public Communications Contact | 01.08.2014 |
Global Hunter Securities LLC
Global Hunter Securities LLC Investment Banks/BrokersFinance Founded in 2005, Global Hunter Securities LLC is a broker/dealer headquartered in New Orleans, Louisiana. The firm is a subsidiary of Seaport Global Holdings LLC. Global Hunter Securities employs a disciplined quantitative and qualitative research approach. They focus on small-cap companies with unique value and above average growth primarily in the following sectors: consumer, energy, healthcare, industrial services and technology. Global Hunter Securities also has analysts specifically focused on special situations and international opportunities. | Corporate Officer/Principal | 01.01.2011 |
SF Capital Group LLC
SF Capital Group LLC Investment ManagersFinance SF Capital Group LLC (SF Capital) is a private equity firm founded in 2009. The firm is headquartered in New York. | Director/Board Member | 01.01.2009 |
HALOZYME THERAPEUTICS, INC. | Investor Relations Contact | - |
Ausbildung von Albert Kildani
Boston College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
HOLOGIC, INC. | Health Technology |
ACADIA PHARMACEUTICALS INC. | Health Technology |
HALOZYME THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
SF Capital Group LLC
SF Capital Group LLC Investment ManagersFinance SF Capital Group LLC (SF Capital) is a private equity firm founded in 2009. The firm is headquartered in New York. | Finance |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | Health Technology |
Global Hunter Securities LLC
Global Hunter Securities LLC Investment Banks/BrokersFinance Founded in 2005, Global Hunter Securities LLC is a broker/dealer headquartered in New Orleans, Louisiana. The firm is a subsidiary of Seaport Global Holdings LLC. Global Hunter Securities employs a disciplined quantitative and qualitative research approach. They focus on small-cap companies with unique value and above average growth primarily in the following sectors: consumer, energy, healthcare, industrial services and technology. Global Hunter Securities also has analysts specifically focused on special situations and international opportunities. | Finance |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Commercial Services |